Pharma Co. Says Ex-CEO's Bias Allegations Come Up Short
By Caroline Simson · January 9, 2025, 7:48 PM EST
Canadian biopharmaceutical company FSD Pharma Inc. is urging the Third Circuit to affirm the enforcement of a $2 million arbitral award against its ex-CEO, arguing Wednesday that the former executive's allegations...
To view the full article, register now.